Quaker Chemical (KWR) Q3 2024 earnings summary

Executive summary

• Q3 2024 net sales were $462.3 million, down 6% year-over-year, with net income of $32.3 million and diluted EPS of $1.81; adjusted EBITDA was $78.6 million, down 7%, with a margin of 17.0%.

• Gross margin held steady at 37.3%, supported by disciplined execution and cost management.

• Year-to-date operating cash flow reached $141.5 million, with a net leverage ratio of 1.6x trailing twelve months adjusted EBITDA.

• Management highlighted resilience amid soft end markets, continued cost discipline, and portfolio simplification.

• Non-GAAP diluted EPS was $1.89, with year-to-date non-GAAP EPS up 4% despite a tough environment.

Financial highlights

• Q3 2024 net sales: $462.3 million (down 6% year-over-year); nine-month sales: $1,395.6 million (down 6.1%).

• Q3 2024 net income: $32.3 million; adjusted EBITDA: $78.6 million (17.0% margin); non-GAAP EPS: $1.89.

• Gross margin was 37.3%, with Q3 2024 gross profit at $172.5 million.

• SG&A decreased year-over-year, reflecting cost management.

• Operating cash flow was $68 million in Q3 and $141.5 million year-to-date; capital expenditures were $19.3 million year-to-date.

Outlook and guidance

• Management expects difficult market conditions to persist through year-end 2024, with soft conditions likely into early 2025.

• Margins are expected to remain within the 37%–38% range in Q4, with generally stable performance.

• Focus remains on cost discipline, new business wins, and operational efficiencies to offset market headwinds.

• Sufficient liquidity is expected to support operations, dividends, share repurchases, and growth opportunities for at least the next twelve months.

• The global cost and optimization program is expected to be substantially complete by Q1 2025.